1688 Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices 

ORIGINAL THRESHOLD ADJUSTED THRESHOLD 

$200 million $260.7 million 

$500 million $651.7 million 

$1 billion $1,303.4 million 

EFFECTIVE DATE: February 12, 2009. 

FOR FURTHER INFORMATION CONTACT: B. 

Michael Verne, Bureau of Competition, 

Premerger Notification Office (202) 326- 

3100. 

Authority: 16 U.S.C. § 7A. 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. E9–411 Filed 1–12–09; 8:45 am] 

BILLING CODE 6750–11–S 

FEDERAL TRADE COMMISSION 

Revised Jurisdictional Thresholds for 

Section 8 of the Clayton Act 

AGENCY: Federal Trade Commission. 

ACTION: Notice. 

SUMMARY: The Federal Trade 

Commission announces the revised 

thresholds for interlocking directorates 

required by the 1990 amendment of 

Section 8 of the Clayton Act. Section 8 

prohibits, with certain exceptions, one 

person from serving as a director or 

officer of two competing corporations if 

two thresholds are met. Competitor 

corporations are covered by Section 8 if 

each one has capital, surplus, and 

undivided profits aggregating more than 

$10,000,000, with the exception that no 

corporation is covered if the competitive 

sales of either corporation are less than 

$1,000,000. Section 8(a)(5) requires the 

Federal Trade Commission to revise 

those thresholds annually, based on the 

change in gross national product. The 

new thresholds, which take effect 

immediately, are $26,161,000 for 

Section 8(a)(1), and $2,616,100 for 

Section 8(a)(2)(A). 

EFFECTIVE DATE: January 13, 2009. 

FOR FURTHER INFORMATION CONTACT: 

James F. Mongoven, Bureau of 

Competition, Office of Policy and 

Coordination, (202) 326-2879. 

Authority: 15 U.S.C. § 19(a)(5). 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. E9–418 Filed 1–12–09; 8:45 am] 

BILLING CODE 6750–01–S 

GENERAL SERVICES 

ADMINISTRATION 

Federal Travel Regulation (FTR); 

Notice of GSA Bulletin FTR 09–02 

AGENCY: Office of Governmentwide 

Policy, General Services Administration 

(GSA). 

ACTION: Notice of a bulletin. 

SUMMARY: This Bulletin informs 

agencies what baggage and seat choice 

fees they may reimburse their 

employees while on official travel. GSA 

Bulletin FTR 09–02 may be found at 

http://www.gsa.gov/bulletin. 

DATES: The bulletin announced in this 

notice became effective on December 31, 

2008, and will remain effective until the 

FTR is amended to reflect the changes. 

FOR FURTHER INFORMATION CONTACT: For 

clarification of content, please contact 

Mr. Cy Greenidge, Office of 

Governmentwide Policy, Office of 

Travel, Transportation and Asset 

Management, at (202) 219–2349. 

Please cite FTR Bulletin 09–02. 

SUPPLEMENTARY INFORMATION: 

A. Background 

Section 301–10.122 of the Federal 

Travel Regulation (FTR) (41 CFR 301– 

10.122) stipulates that Federal 

employees, with few exceptions, must 

use coach-class accommodations. As a 

result of many airlines now charging 

additional fees for checked baggage, as 

well as for seat choice in the coach-class 

cabin, this bulletin was developed to 

clarify which of these fees may be 

reimbursed by Federal agencies. 

B. Procedures 

Bulletins regarding the Federal Travel 

Regulation are located on the Internet at 

http://www.gsa.gov/bulletin as Federal 

Travel Regulation bulletins. 

Dated: January 5, 2009. 

Russell H. Pentz, 

Assistant Deputy Associate Administrator, 

Office of Travel, Transportation, and Asset 

Management. 

[FR Doc. E9–434 Filed 1–12–09; 8:45 am] 

BILLING CODE 6820–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day–09–0556] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Maryam I. Daneshvar, 

CDC Acting Reports Clearance Officer, 

1600 Clifton Road, MS–D74, Atlanta, 

GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Assisted Reproductive Technology 

(ART) Program Reporting System— 

Revision—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Section 2(a) of Pub. L. 102–493 

(known as the Fertility Clinic Success 

Rate and Certification Act of 1992 

(FCSRCA), 42 U.S.C. 263a–1(a)) requires 

Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices 1689 

that each assisted reproductive 

technology (ART) program shall 

annually report to the Secretary through 

the Centers for Disease Control and 

Prevention: (1) Pregnancy success rates 

achieved by such ART program, and (2) 

the identity of each embryo laboratory 

used by such ART program and whether 

the laboratory is certified or has applied 

for such certification under the Act. The 

required information is currently 

reported by ART programs to CDC as 

specified in the Assisted Reproductive 

Technology (ART) Program Reporting 

System (OMB No. 0920–0556, exp. 9/ 

30/2009). CDC seeks to extend OMB 

approval for a period of three years and 

incorporate a minor change in wording 

to one question. In addition, the revised 

total burden estimate includes an 

anticipated increase in the number of 

respondents and a slight decrease in the 

average number of responses per 

respondent. The burden estimate per 

response has also been revised to 

include an adjustment for data 

validation procedures. 

The currently approved program 

reporting system, also known as the 

National ART Surveillance System 

(NASS), includes information about all 

ART cycles initiated by any of the ART 

programs in the United States. An ART 

cycle is considered to begin when a 

woman begins taking ovarian 

stimulatory drugs or starts ovarian 

monitoring with the intent of having 

embryos transferred. The system also 

collects information about the 

pregnancy outcome of each cycle, as 

well as a number of data items deemed 

important to explain variability in 

success rates across ART programs and 

across individuals. Data elements and 

definitions currently in use reflect 

CDC’s consultations with 

representatives of the Society for 

Assisted Reproductive Technology 

(SART), the American Society for 

Reproductive Medicine, and RESOLVE, 

the National Infertility Association (a 

national, nonprofit consumer 

organization), as well as a variety of 

individuals with expertise and interest 

in this field. 

Respondents are the 480 ART 

programs in the United States. 

Approximately 420 clinics are expected 

to report an average of 286 ART cycles 

each. Ten percent of responding clinics 

will be randomly selected to participate 

in full validation of selected ART cycle 

records and an abbreviated validation of 

selected cycles resulting in live birth. 

All information is collected 

electronically. Respondents have the 

option of entering data directly into a 

Web-based NASS interface or of 

transmitting system-compatible files 

extracted from other record systems. 

The ART program reporting system 

allows CDC to publish an annual report 

to Congress as specified by the FCSRCA 

and to provide information needed by 

consumers. 

There are no costs to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

per response 

(in hours) 

Total burden 

(in hours) 

ART Programs ...................................... NASS .................... 420 286 38/60 76,076 

Dated: January 2, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–405 Filed 1–12–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee on Procedures 

Reviews, Advisory Board on Radiation 

and Worker Health (ABRWH), National 

Institute for Occupational Safety and 

Health (NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention, announces the 

following meeting for the 

aforementioned subcommittee: 

Time and Date: 9:30 a.m.–5 p.m., January 

28, 2009. 

Place: Cincinnati Airport Marriott, 2395 

Progress Drive, Hebron, Kentucky 41018. 

Telephone (859) 334–4611, Fax (859) 334– 

4619. 

Status: Open to the public, but without a 

public comment period. To access by 

conference call dial the following 

information 1(866) 659–0537, Participant 

Pass Code 9933701. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation Program 

Act of 2000 to advise the President on a 

variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that have 

been promulgated by the Department of 

Health and Human Services (HHS) as a final 

rule; advice on methods of dose 

reconstruction which have also been 

promulgated by HHS as a final rule; advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort (SEC). 

In December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, which 

subsequently delegated this authority to CDC. 

NIOSH implements this responsibility for 

CDC. The charter was issued on August 3, 

2001, renewed at appropriate intervals, and 

will expire on August 3, 2009. 

Purpose: The Advisory Board is charged 

with (a) Providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. The Subcommittee on Procedures 

Reviews was established to aid the Advisory 

Board in carrying out its duty to advise the 

Secretary, HHS, on dose reconstruction. It 

will be responsible for overseeing, tracking, 

and participating in the reviews of all 

procedures used in the dose reconstruction 

process by the NIOSH Office of 

Compensation Analysis and Support (OCAS) 

and its dose reconstruction contractor. 

Matters To Be Discussed: The agenda for 

the Subcommittee meeting includes: a 

discussion of proposed new versions of the 

computer-assisted telephone interview 

scripts and procedures NIOSH uses to 

interview claimants at the outset of the dose 

reconstruction process; a discussion of 

ORAUT–OTIB–0054 (‘‘Fission and 

Activation Product Assignment for Internal 

Dose-Related Gross Beta and Gross Gamma 

Analyses’’) and ORAUT–OTIB–0066 

(‘‘Calculation of Dose from Intakes of Special 

Tritium Compounds’’); and, a continuation of 

the comment-resolution process for other 

dose reconstruction procedures under review 

by the Subcommittee.